Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
Saved in:
| Title: | Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. |
|---|---|
| Authors: | Venkatraman N; Jenner Institute, University of Oxford, United Kingdom., Ndiaye BP; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Bowyer G; Jenner Institute, University of Oxford, United Kingdom., Wade D; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Sridhar S; Jenner Institute, University of Oxford, United Kingdom., Wright D; Jenner Institute, University of Oxford, United Kingdom., Powlson J; Jenner Institute, University of Oxford, United Kingdom., Ndiaye I; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Dièye S; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Thompson C; Jenner Institute, University of Oxford, United Kingdom., Bakhoum M; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Morter R; Jenner Institute, University of Oxford, United Kingdom., Capone S; ReiThera Srl, Rome, Italy., Del Sorbo M; ReiThera Srl, Rome, Italy., Jamieson S; Jenner Institute, University of Oxford, United Kingdom., Rampling T; Jenner Institute, University of Oxford, United Kingdom., Datoo M; Jenner Institute, University of Oxford, United Kingdom., Roberts R; Jenner Institute, University of Oxford, United Kingdom., Poulton I; Jenner Institute, University of Oxford, United Kingdom., Griffiths O; Jenner Institute, University of Oxford, United Kingdom., Ballou WR; GlaxoSmithKline Biologicals, Rixensart, Belgium., Roman F; GlaxoSmithKline Biologicals, Rixensart, Belgium., Lewis DJM; National Institute for Health Research/Imperial Clinical Research Facility, Hammersmith Hospital, London, United Kingdom., Lawrie A; Jenner Institute, University of Oxford, United Kingdom., Imoukhuede E; Jenner Institute, University of Oxford, United Kingdom., Gilbert SC; Jenner Institute, University of Oxford, United Kingdom., Dieye TN; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Ewer KJ; Jenner Institute, University of Oxford, United Kingdom., Mboup S; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Hill AVS; Jenner Institute, University of Oxford, United Kingdom. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2019 Apr 08; Vol. 219 (8), pp. 1187-1197. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
